Recruiting studies: Drug Susceptible Pulmonary Tuberculosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Novel Triple-dose Tuberculosis Retreatment Regimen
Phase 3 · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT04260477 Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
Phase 2 · 13 location(s) · Gates Medical Research Institute · NCT07525427 Shortened Regimen for Drug-susceptible TB in Children
Phase 3 · 9 location(s) · Johns Hopkins University · NCT06253715 A PAN-USR TB Multi-Center Trial
Phase 3 · 3 location(s) · Shenzhen Third People's Hospital · NCT06905522 Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susc
Phase 2 · 4 location(s) · Gates Medical Research Institute · NCT07517445 Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculo
NA · 1 location(s) · Bahirdar University · NCT07387601 A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide
Phase 2 · 1 location(s) · TASK Applied Science · NCT06748937

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.